Anemia in the Elderly: Pathogenesis
Anemia in the Elderly: Pathogenesis
批准号:
7591119
负责人:
JEFFREY S FRIEDMAN
金额:
$38.07万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-05-01 至 2011-03-31
关键词:
AccountingAgeAge-YearsAnemiaCell AgingChronicElderlyErythrocyte MembraneErythrocyte SurvivalErythrocytesErythroidErythroid Progenitor CellsHemoglobinHemoglobin concentration resultIndividualInfectionInterleukin-6Kidney FailureLengthLongevityMalignant NeoplasmsMeasurementMeasuresMitochondrial DNANaturePathogenesisPatientsPhosphatidylserinesPopulationProductionProteinsSerumStructureTestosteroneVariantagedglutathione peroxidasegranulocytehexokinasemalemennormal agingolder patientoxidative damageperipheral bloodprogenitortelomere
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Anemia is common in the elderly, often as a result of known causes such as renal failure, cancer, or chronic infection. But even when patients with known causes are eliminated from consideration, hemoglobin levels decline during ageing. We will study such patients over the age of 75 and compare those whose with hemoglobin levels in the highest decile with those in the lowest decile. Patients aged 30 to 40 years will serve as controls. The elderly patients and controls will be studied for evidence of erythropoietic progenitor cell (EPC) senescence and for abnormalities of circulating erythrocytes. With circulating granulocytes serving as surrogates for EPC we will examine mtDNA and telomere length and G loop structure. Erythrocyte survival will be estimated by CO levels and red cell hexokinase activity; oxidative damage to erythrocytes will be assessed by estimating GSSG/GSH, glutathione peroxidase, carbonyl proteins, TEARS; exposure of phosphatidylserine on erythrocyte membranes will be documented. Serum IL-6 measurements and in males serum testosterone levels will be determined. Parameters that show differences between the highest and lowest deciles will be candidate causes of anemia in the elderly. If such differences also occur among controls they could account for the broad normal variation in hemoglobin levels.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hemolytic Anemia: Biochemical, Molecular and Proteomic Diagnostics
-
批准号:7654467
-
项目类别:
-
资助金额:$47.48万
-
财政年份:2009
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Hemolytic Anemia: Biochemical, Molecular and Proteomic Diagnostics
-
批准号:7934640
-
项目类别:
-
资助金额:$47.48万
-
财政年份:2009
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Oxidized Proteome of Normal/Sideroblastic Erythroid Cell
-
批准号:7591099
-
项目类别:
-
资助金额:$23.74万
-
财政年份:2008
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Oxidized Proteome of Normal/Sideroblastic Erythroid Cell
-
批准号:7387295
-
项目类别:
-
资助金额:$27.96万
-
财政年份:2008
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Anemia in the Elderly: Pathogenesis
-
批准号:7407984
-
项目类别:
-
资助金额:$38.07万
-
财政年份:2007
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Anemia in the Elderly: Pathogenesis
-
批准号:7797541
-
项目类别:
-
资助金额:$37.78万
-
财政年份:2007
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Reactive Oxygen Species in Anti-Viral Airway Host Defense
-
批准号:7497538
-
项目类别:
-
资助金额:$27.88万
-
财政年份:2007
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
DIGE Package: Variable Mode Imager and Spot Picker
-
批准号:7214952
-
项目类别:
-
资助金额:$21.51万
-
财政年份:2007
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
LEPTIN TREATMENT FOR PREVENTION OF THE METABOLIC AND ENDOCRINE SEQUELAE
-
批准号:7206993
-
项目类别:
-
资助金额:$69.99万
-
财政年份:2005
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Pathogenesis and Therapy of Sideroblastic Anemia
-
批准号:6789691
-
项目类别:
-
资助金额:$20.27万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Pathogenesis and Therapy of Sideroblastic Anemia
-
批准号:6761972
-
项目类别:
-
资助金额:$4.22万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Pathogenesis and Therapy of Sideroblastic Anemia
-
批准号:6711204
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Pathogenesis and Therapy of Sideroblastic Anemia
-
批准号:6839428
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Pathogenesis and Therapy of Sideroblastic Anemia
-
批准号:7008475
-
项目类别:
-
资助金额:$32.81万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Leptin Treatment for Prevention of Metabolic & Endocrine
-
批准号:7041485
-
项目类别:
-
资助金额:$76.1万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Pathogenesis and Therapy of Sideroblastic Anemia
-
批准号:6612104
-
项目类别:
-
资助金额:$6.93万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Pathogenesis and Therapy of Sideroblastic Anemia
-
批准号:7175400
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
CYCLOPHILIN C FUNCTION
-
批准号:2386364
-
项目类别:
-
资助金额:$8.16万
-
财政年份:1997
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
CYCLOPHILIN C FUNCTION
-
批准号:6388426
-
项目类别:
-
资助金额:$11.59万
-
财政年份:1997
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
CYCLOPHILIN C FUNCTION
-
批准号:6043686
-
项目类别:
-
资助金额:$11.59万
-
财政年份:1997
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: